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1. Introduction 
The microsomal monoxygenase system catalyzes the 
biotransformation of fatty acids, steroids, drugs, carci- 
nogens and various other compounds [ 1 ] . In this system, 
the reducing equivalents are transferred from NADPH 
to cytochrome P-4.50 through a flavoprotein, generally 
known as NADPH-cytochrome c reductase or NADPH 
cytochrome P-450 reductase. In rat liver microsomes, 
the number of cytochrome P-450 molecules is 10-20- 
fold greater than the reductase [2]. It has been 
suggested that these enzymes are rigidly organized in 
individual units of electron transfer complexes with 
several cytochrome P-450 molecules surrounding a 
reductase molecule [3]. According to current membrane 
theories [4] , it is difficult to envision how the reductase 
(mol. wt 79 000) [5] can be rigidly associated simul- 
taneously and react efficiently with 1 O-20 cytochrome 
P-450 molecules (mol. wt 50 000) [6]. Orrenius and 
Ernster [ 1 ] have discussed the possible lateral mobility 
of these enzymes in the membrane. In the present study, 
the chemical modification approach of Franklin and 
Estabrook [3] was used to study the molecular associ- 
ation of these two enzymes in rat liver microsomes. 
The results do not satisfy the criteria for the rigid 
organization as proposed previously [3] and indicate 
that the monoxygenase enzymes may have translational 
mobility. 
2. Materials and methods 
Mersalyl (sodium 0-[(3-hydroxymercuri-2-methoxy- 
propyl)carbamyl] phenoxyacetate) was purchased from 
Schwarz/Mann Co. NADPH, NADP, isocitric acid, 
isocitrate dehydrogenase, cytochrome c, and bovine 
serum albumin were purchased from Sigma Chemical 
Co. Ethylmorphine . HCl and phenobarbital were gifts 
from Merck and Co. Hepatic microsomes were prepared 
[7] from male Long-Evans rats (average body weight 
75 g) which had been pretreated with three daily intra- 
peritoneal injections of phenobarbital (75 mg/kg). 
NADPH-cytochrome c reductase and ethylmorphine 
N-demethylase activities were assayed as described 
previously [8] . NADPH-dependent cytochrome P-450 
reduction was assayed at 30°C in an anaerobic cuvette 
equipped with side-arms. The cuvette, containing all 
the reagents was evacuated and refilled with Nz for 
eight cycles, and CO was substituted for Nz finally. 
Both gases had been deoxygenated with BASF cata- 
lyst (Ace Glass, Vineland, N. J.). 
3. Results and discussion 
Mersalyl is noted for its reactivity with sulfhydryl 
groups, and NADPH-cytochrome c reductase has been 
suggested as the primary target of its inhibition of the 
mono-oxygenase system [3]. The effects of mersalyl 
on the microsomal NAbPH-cytochrome c reductase 
and ethylmorphine N-demethylase activities are shown 
in fig.1. A similar pattern of inhibition was observed 
for both enzymic activities. In agreement with the 
observation of Franklin and Estabrook [3] , the enzyme 
activities were rather insensitive to lower levels of 
mersalyl and then responded drastically to further 
increments of the inhibitor in the concentration range 
of 25-40 nmol of mersalyl per mg microsomal protein. 
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Fig.1. Inhibition of ethylormorphine demethylase and NADPH- 
cytochrome c reductase activities by mersalyl. Microsomes (1 
mg protein/ml) were treated with mersalyl at 0°C for 30 min in 
a medium containing TKM buffer (50 mM Tris HCl, 150 mM 
KC1 and 10 mM MgCl,, pH 7.4) and 6.5 mM ethylmorphine. 
The demethylase activity was assayed at 37°C with 0.85 mg 
microsomal protein per ml and with an incubation period of 
15 min [ 121. The 100% corresponds to 19 nmol of formal- 
dehyde produced per min per mg of microsomal protein. For 
the reductase assay, the mersalyl treated microsomes were 
further incubated at 37°C for 7 min before added to the 
reductase assay mixture (containing TKM buffer, 1 mM KCN, 
0.04 mM cytochrome c and 0.2 mM NADPH) to a concen- 
tration of 0.05 mg/ml. The initial rate was recorded in the 
first minute at 37°C. The 100% corresponds to 226 nmol of 
cytochrome c reduced per min per mg microsomal proteins. 
The reaction of mersalyl with the monoxygenase 
enzymes was not instantaneous. Its inhibitory action 
was affected by factors such as the type and ionic 
strength of the buffer, the presence or absence of 
NADPH [3], and the temperature and duration of the 
treatment. When the incubation conditions of the 
cytochrome c reductase and ethylmorphine demeth- 
ylase assays were made as similar as possible, mersalyl 
inhibited both enzyme activities to about the same 
extent (tig.1) consistent with earlier observations [3] . 
The observation that mersalyl inhibited both NADPH- 
cytochrome c reductase and ethylmorphine demethy- 
lase to approximately the same extent has been used to 
support the thesis of a rigid association between cyto- 
chrome P-450 and the reductase [3]. However, the 
data in fig. 1 are also consistent with the concept that 
these enzymes are not rigidly organized and have 
lateral mobility in a fluid mosaic membrane [4] . The 
mersalyl modification is expected to decrease the 
amount of functional NADPH-cytochrome P-450 
reductase and thus inhibits the rate of the reduction 
of cytochrome P-450, which is beleived to be the rate- 
limiting step in the ethylmorphine demethylation 
reaction [9]. 
The effects of mersalyl on the rate and extent of 
the NADPH-dependent cytochrome P-450 reduction 
are illustrated in fig.2. In the absence of mersalyl, the 
rate of reduction was fast and most of the reaction 
was accomplished in the first 30 sec. In the presence 
of 40 or 45 nmol mersalyl/mg microsomal protein, 
the rate of the reduction was significantly retarded, 
but almost all of the cytochrome P-450 in the system 
could still be reducted in a period of 20-25 min. The 
results of some of this series of experiments are 
summarized in table 1. The different amounts of cyto- 
chrome P-450 reduced in the first 30 set reflect the 
rate of the reduction which was inhibited by mersalyl; 
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Fig.2. Inhibition of NADPH-cytochrome P-450 reductase by 
mersalyl. Microsomes (1 mg protein/ml) were treated with 
mersalyl at 0°C for 30 min in a medium containing TKM 
buffer and 6.5 mM ethylmorphine. After deoxygenation, 
the reaction was initiated under an atmosphere of CO, by 
adding NADPH (0.4 mM) to the microsomal suspension in an 
anaerobic cuvette. The absorbance changes at 450-490 nm 
was recorded with an Aminco-Chance DW-2 spectrophoto- 
meter. The reading was set at the origin at zero time for each 
experiment. The time between the initial mixing and the first 
recording was about 30 sec. The arrows indicate the addition 
of sodium dithionite for the reduction of all the cytochrome 
P-450 in the system. The amounts of mersalyl used in nmol/mg 
microsomal protein were: 45 (A. . A), 40 (e------•), and 
0 Co- 0). 
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Table 1 
Effect of mersalyl on the NADPH-dependent reduction 
of microsomal cytochrome P-450 a 
Mersalyl Reduced in % P-450 P-450 content 
(nmol/mg) 30 set (nmol) Reducible (nmol) 
0 4.18 >9Ob 6.59 
36 3.43 96 5.14 
40 1.04 94 4.81 
4oc 0.69 94 4.45 
45 0.82 96 4.56 
55 0 0 4.26 
Conditions were similar to those described in fig.2. The P- 
450 contents were determined at the end of the reaction 
with the method of Omura and Sato [ lo]. 5% P-450 reduc- 
ible was calculated from the amount of cytochrome P-450 
that could be reduced by NADPH and the P-450 content. 
Sodium dithionite was added before the NADPH-depend- 
ent reduction was complete. 
Microsomes were treated at 0” C for 1.5 hr. 
however, mersalyl treatment did not limit the extent 
of the cytochrome P-450 reduction. At 55 nmol/mg, 
mersalyl inactivated the reductase completely and, 
hence, no cytochrome P-450 could be reduced 
enzymically. As is shown in the last column of table 
1, partial denaturation of cytochrome P-450 was also 
noted under these experimental conditions. 
In discussing the molecular organization of the 
microsomal electron transport system, Franklin and 
Estabrook [3] have advanced the criterion that in a 
‘rigid’ system the structural organization precludes an 
accessibility for the interaction between electron 
carriers from one complex to electron acceptors of 
another complex; whereas in a ‘non-rigid’ system, 
inter-complex electron transport is possible. In a 
mersalyl treated microsomal sample, when the rate 
of NADPH-dependent cytochrome P-450 reduction is 
inhibited by 50% as a result of the inactivation of the 
reductase, the ‘rigid’ model predicts that only 50% of 
the cytochrome P-450 can be reduced by NADPH. On 
the other hand, the ‘non-rigid’ model predicts that all 
of the cytochrome P-450 can be reduced enzymically. 
The data in fig.2 and table 1 definitely favor the 
‘non-rigid’ over the ‘rigid’ model. Results obtained 
from similar chemical modifications studies on the 
cytochrome b5 system have lent support to the 
random distribution and rapid lateral mobility of the 
cytochrome bS system [ 111. The observed slow rate 
of cytochrome P-450 reduction in the mersalyl 
modified sample (fig.2) suggests that cytochrome P- 
450 and its reductase do not have translational move- 
ments as fast as have been reported for,cytochrome bs 
and cytochrome b5 reductase [l 1, 121. It may be 
argued that inter-complex electron transfer is also 
possible in a rigid system, if there is electron transfer 
reaction between cytochrome P-450 molecules. 
Although this type of electron transfer, if it can occur 
at all, would not be expected to take place to a great 
extent in a ‘rigid’ system, it cannot be completely ruled 
out at the present time. 
In the light of the present observations, we have to 
consider that a non-rigid oranization of the mono- 
oxygenase enzymes in the membrane is quite possible. 
The rate and extent of their mobilities in the membrane 
remain to be determined. Cytocrhome P-450 is known 
to be present in large molar excess to NADPH-cyto- 
chrome P-450 reductase. A non-rigid association and 
the lateral mobility of these enzymes would enable the 
reductase to react efficiently with all of the cytochrome 
P-450 molecules and would also allow them to inter- 
act with the cytochrome b5 electron transfer system. 
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